Can-Fite BioPharma Ltd. Gains 30.43%
Wed, Feb 19, 2020 at 05:30 PM
Can-Fite BioPharma Ltd. (CANF:NYSEMKT) soared at $1.65, representing a gain of 30.4%. The stock got featured on our News Catalysts scanner on Tue 18 Feb 20 at 09:18 AM in the 'BIOTECH' category. From Tue 28 Jan 20, the stock recorded 35.71% Up Days and 33.33% Green Days
About Can-Fite BioPharma Ltd. (CANF:NYSEMKT)
Can Fite Biofarma Ltd is a clinical stage biopharmaceutical company. It develops orally bioavailable small molecule therapeutic products for the treatment of autoimmune-inflammatory, oncological and ophthalmic diseases.
Top 10 Gainers:
- Zomedica Pharmaceuticals Corp. (ZOM:NYSEMKT), 79.64%
- Cyclerion Therapeutics, Inc. (CYCN:NASDAQ), 44.55%
- Myomo, Inc. (MYO:NYSEMKT), 43.41%
- Enphase Energy, Inc. (ENPH:NASDAQ), 42.44%
- ShotSpotter, Inc. (SSTI:NASDAQ), 32.56%
- Viveve Medical, Inc. (VIVE:NASDAQ), 32.35%
- Can-Fite BioPharma Ltd. (CANF:NYSEMKT), 30.43%
- Altisource Asset Management Corporation (AAMC:NYSEMKT), 30.4%
- LMP Automotive Holdings, Inc. (LMPX:NASDAQ), 28.41%
- Arcus Biosciences, Inc. (RCUS:NYSE), 26.63%